M&A / successionCH· 1mo ago
Samsung Biologics to launch takeover bid for PolyPeptide in September | MWC Sandbox/Syndication
Samsung Biologics plans a September takeover bid for PolyPeptide Group worth 1.46 billion Swiss francs ($1.80 billion), with the objective to delist PolyPeptide from the Swiss market.
Intent
WATCH· 54intent / 100
▸ why this score▾ score breakdown
- default: OON discount · × 0.75-0.3
- Final score (ambiguity-dampened) · default=54+54
- V2 winner: default · default=54+0
Go-to-market brief
Daily 5 RWA signals
Five signals in your inbox each morning. Email only.
Free. The daily 5 lands at 07:00 UTC, nothing else. One-click unsubscribe in every email.